BROOKSIDE 13G REGENXBIO AS OF 9/24/2015

Company

REGENXBIO Inc.

Filed

September 24, 2015

Accession Number

0001028348-15-000012

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →